Evidence map›Paper›PMID 11022786›Full record

ReviewVirus genes2000

Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses.

H G Burgert, J H Blusch

Abstract readReview
PubMed
In one paragraph

Review in Virus genes, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential.Frontiers in cellular and infection microbiology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Isolation and genetic characterization of canine adenovirus type 2 from a domestic dog showing neurological symptoms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

H G BurgertMax von Pettenkofer-lnstitut, Lehrstuhl Virologie, Genzentrum der Ludwig-Maximilians-Universität, München, Germany. burgert@lmb.uni-muenchen.de
J H Blusch
Ludwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent viruses have evolved multiple strategies to escape the host immune system. One important prerequisite for efficient viral reproduction in the face of an ongoing immune response is prevention of premature lysis of infected cells. A number of viruses achieve this goal by interfering with antigen presentation and recognition of infected cells by cytotoxic T cells (CTL). Another viral strategy aims to block apoptosis triggered by host defense mechanisms. Both types of strategies seem to be realized by human adenoviruses (Ads). The early transcription unit E3 of Ads encodes proteins that inhibit antigen presentation by MHC class I molecules as well as apoptosis induced by tumor necrosis factor alpha (TNF-alpha) and Fas ligand (FasL). Here, we will describe the organization of the E3 regions of different Ad subgroups and compare the structure and functions of the known immunomodulatory E3 proteins.

Indexed as

Adenovirus E3 ProteinsAdenoviruses, HumanAdenovirus Infections, HumanAmino Acid SequenceAntigen PresentationAntigens, ViralApoptosisfas ReceptorHumansMajor Histocompatibility ComplexMolecular Sequence DataTranscription, GeneticTumor Necrosis Factor-alphaAdenovirus E3 ProteinsAntigens, Viralfas ReceptorTumor Necrosis Factor-alpha

Identifiers

PMID11022786
OpenAlexW1539464315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.